Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug.

Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug.
复制标题

DOI:
10.1167/iovs.63.4.26
复制
发表时间:
2022-04-01
影响因子:
4.4
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

To characterize the ocular hypotensive and pharmacological properties of QLS-101, a novel ATP-sensitive potassium (KATP) channel opening prodrug. Ocular hypotensive properties of QLS-101 were evaluated by measuring IOP with a handheld rebound tonometer after daily topical ocular instillation of 0.2% (n = 5) or 0.4% QLS-101 (n = 10) in C57BL/6J mice. KATP channel specificity was characterized in HEK-293 cells stably expressing human Kir6.2/SUR2B subunits and assessed for off-target interactions using a receptor binding screen. Conversion of QLS-101 prodrug to its active moiety, levcromakalim, was evaluated in vitro using human ocular tissues and plasma samples and after incubation with human phosphatase enzymes (2.0 nM-1.0 µM). C57BL/6J mice treated once daily with 0.2% QLS-101 exhibited significant (P < 0.01) IOP reductions of 2.1 ± 0.4 mmHg after five days; however, a daily attenuation of the effect was noted by 23h post-dose. By comparison, treatment with 0.4% QLS-101 lowered IOP by 4.8 ± 0.7 mm Hg (P < 0.0001) which was sustained for 24 hours. Unlike levcromakalim, QLS-101 failed to induce KATP channel activity in HEK-Kir6.2/SUR2B cells consistent with its development as a prodrug. No off-target receptor effects were detected with either compound. In vitro ocular tissue conversion of QLS-101 prodrug was identified in human iris, ciliary body, trabecular meshwork, and sclera. Alkaline phosphatase was found to convert QLS-101 (mean Km = 630 µM, kcat = 15 min−1) to levcromakalim. QLS-101 is a novel KATP channel opening prodrug that when converted to levcromakalim shows 24-hour IOP lowering after once-daily topical ocular administration.
DOI: 10.1371/journal.pone.0179345
发表时间: 2017-06-08
期刊: PLOS ONE
影响因子: 3.7
作者:
Chowdhury, Uttio Roy;Bahler, Cindy K.;Fautsch, Michael P.
通讯作者: Fautsch, Michael P.
DOI: 10.1177/1120672121998913
发表时间: 2021-03-02
影响因子: 1.7
作者:
Mehta, Amy A.;Kanu, Levi N.;Edward, Deepak P.
通讯作者: Edward, Deepak P.
DOI: 10.1016/j.ophtha.2014.05.013
发表时间: 2014-11-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Tham, Yih-Chung;Li, Xiang;Cheng, Ching-Yu
通讯作者: Cheng, Ching-Yu
DOI: 10.3389/fmicb.2018.00415
发表时间: 2018
影响因子: 5.2
作者:
Kers JA;Sharp RE;Defusco AW;Park JH;Xu J;Pulse ME;Weiss WJ;Handfield M
通讯作者: Handfield M
DOI: 10.1136/bjo.2005.081224
发表时间: 2006-03-01
影响因子: 4.1
作者:
Quigley, HA;Broman, AT
通讯作者: Broman, AT